Aims: Elderly patients have an increasing prevalence of illness that requires consideration of critical care and invasive ventilatory support. Although critical care of even the very elderly can provide value, with increasing age the potential risks of treatment and diminishing returns with respect to quality and quantity of life result in a need for careful evaluation. Variable combinations of impaired organ function, active disease and residual pathology from past disease and injury all affect critical care, with the consequence that the elderly are a very heterogeneous population. Recognizing that critical care is a limited resource, it is important to identify patients who may be at increased risk or least likely to benefit from treatment. Patients with functional impairments, nutritional deficiencies and multiple comorbidities may be at highest risk of poor outcomes. Those with very severe disease, extreme age and requirements for prolonged ventilatory support have high in-hospital mortality. Functional impairments, comorbidities and severity of illness are usually more important considerations than chronologic age. The objective of this review is to identify how common problems of the elderly affect critical care and decisions concerning use of invasive ventilatory
During the 20th century, improved medical care and public health successes have increased the average life span by 20 years. A further 10-year increase is anticipated by 2050.1 In combination with an increased birthrate following World War II, these factors are leading to a marked increase in the number of older adults. In the USA the proportion of the population over 65 years is projected to increase from 12.4% in 2000 to 19 .6% in 2030, an increase from 35 million to 71 million. Individuals over age 80 years will increase from 9.3 million to 19.5 million. These increases are particularly significant because although medical success have improved life span, elderly patients continue to suffer from chronic illnesses, injury and disability.
Correspondence: Christopher Nielson, MD, Medical Service, 1000 Locust St, Reno, NV 89502, USA E-mail: christopher.nielson @med.va.gov This work was supported by funding from a grant from the American Heart Association and was performed using facilities of the Department of Veterans Affairs, Boise, ID, USA Intensive care resources Elderly patients are at particular risk from illnesses including myocardial infarction, sepsis and respiratory failure that may require intensive care. In the early 1990s, patients over age 65 years occupied 58% of all 2 adult intensive care unit beds. Recent estimates indicate that patients over age 65 utilize more than half of intensive care unit (ICU) days and that there is a 700% increase in ICU use from under age 65 to over age 75.3 As the proportion and numbers of elderly patients increase, greater demands for intensive care of the elderly will increasingly lead to situations in which critical care resources are inadequate. Recognizing that expansion of critical care facilities as well as provision of intensive care have very high costs,4 there will invariably be situations in which decisions are required to determine which patients do not receive intensive care services. Because age, comorbidities and severity of illness are very relevant to the risks and outcomes of critical care, it is most important to understand how these factors may help identify the patients at risk and those most likely to benefit from intensive care. Crtical care of the elderly C Nielson et al. 44 Higher intensity care may be assumed to be invariably desirable, a 'one-tail' statistical analysis in which the value of critical care must exceed the risk of adverse effects. However, intensive care with invasive interventions, multiple medications and a stressful environment can clearly have adverse complications. It is of importance to identify those patients in whom the risks of adverse events may exceed the potential value of intensive care. Appropriate patient selection is central to optimization of resource utilization as well as quality of care. Although age may identify a subset of patients at increased risk of invasive interventions, ageassociated functional deficits and comorbidities are of greater specific importance with respect to critical care outcomes.
Considerations associated with age
Many studies indicate that critical care and mechanical ventilation of elderly patients is associated with increased complications and mortality.5-13 However, critical care risks are not simply a function of age but rather are more related to functional disabilities and comorbidities that may be prevalent with age. Ageassociated changes may be further considered as physiological changes that consistently occur with age, diseases that are prevalent with age and residual effects of past disease and injury. Impairments in organ function are one of the more predictable aspects of ageing and provide an initial basis for clinical considerations. Active disease processes and residual effects from remote injury or illness are variable but important since deficits can markedly affect prognosis and potential outcome. Unfortunately, multiple problems have a compounding effect with respect to risk. Diagnostic and therapeutic approaches become complex. Multiple medications are associated with increased interactions and adverse effects. Nutritional deficiencies and depression become more likely. Thus, not simply because of age but rather because functional deficits and comorbidities are more common with age, elderly patients may be at increased risk from the invasive interventions associated with critical care.
The pursuit of any intervention requires a decision that potential value exceeds any risk. The concept of futility, an extreme case in which interventions have no value, is sometimes raised in care of the elderly. Since there is a biological endpoint to life, at some point medical interventions have diminishing returns with decreasing effects on outcome. However, futility is rarely a useful consideration. Not only do health care providers frequently disagree with respect to any specific case,14-16 but it is rare that all options can be absolutely Chroric Rspratory DLsese known to have no chance of improving outcome. Probabilities of how much time might be added to life must be estimated in a context of acceptable disability. Since even short periods of survival can, in some circumstances, have major value to the patient, it is difficult to set definitions for when an intervention is futile. Futility infers that objectives cannot be achieved. While the physician can best determine which therapeutic options may have efficacy and which objectives may be feasible, the patient and family must identify overall objectives. Rather than focusing on possible futility, decisions that contrast potential value with risks and costs may be both more feasible and more useful.
Trauma is a common problem for the elderly that exemplifies critical care considerations. Older patients requiring critical care for trauma have increased mortality and increased complications.5 Unfortunately, both the risks of suffering trauma17 and the risks of subsequent care may increase with age. Falls, burns, pedestrian and automobile accidents are all more common, while the elderly also suffer increased subsequent morbidity and mortality.18 Although risks increase with age, outcomes are more related to severity of injury, prior functionality, nutrition and comorbidities. Comorbid illness increases from about 17% at age 40 to 65% by age 75. Patients with more comorbidities have worse outcome regardless of age.19 Older patients suffer more severe injury and have greater baseline impairment in physiological status.20 Elderly patients may be at particular risk from central nervous system (CNS) injury. If the Glasgow coma score is 5 or less then only 2% of elderly have a successful recovery in contrast to 38% of younger patients.22
Thus, although age is associated with worse outcome, the risks from trauma are more directly to severity of injury, impaired baseline physiological status and comorbid conditions. Evaluation of critical care can be complicated by the increased frequency of do-not-resusitate (DNR) orders and more frequent withdrawal of support in the 23 elderly. However, recognizing that only 20% of patients who suffer a cardiac arrest survive to discharge,24 DNR orders may not be responsible for major differences in mortality. In contrast, early withdrawal of care or initial refusal of critical care could have marked ramifications with respect to cost. Since decisions to withhold mechanical ventilation increase 15% with each decade of life,25 a decreased level of care could be very relevant in studies that have identified reduced costs for critical care of the elderly. 26 Although age is associated with increased risks for [27] [28] [29] mortality and adverse outcomes with critical care, the relative risks and potential value are dependent 26,30 35 ventilation.
3 Elderly patients may tolerate mechanical ventilation with successful outcomes36 and those selected for critical care can have lower costs and similar in-hospital mortality to younger 26, 37 patients.
Although additional considerations are often of greater importance, increasing age has been associated with risk for poor outcome. After adjustment for severity of illness, functional status, sex, ethnicity and income, each year of age may be associated with approximately a 1% six-month risk of death for those under age 70 and 2% increased risk for patients over age 70.28 Mortality within a year of critical care may increase from 31% for younger patients to 49% for patients over age 65.38 Patients over age 70 with acute lung injury may have significantly longer duration of mechanical ventilation, longer time in intensive care and decreased one-month survival even after adjustment for severity of illness.39 It is likely that patient selection is responsible for differences between studies showing poor outcome and higher cost with age,39 in contrast to those showing similar outcome and lower costs.26 The contrast between evidence that older patients have reduced costs and reasonable outcomes26 and indications that costs are higher and outcomes poor with age40 suggests that age alone is a poor criterion for predicting outcome. Factors including functional status, nutrition and comorbidities are clearly relevant to identification of elderly patients who may benefit from critical care.
Frailty, functional status and nutrition
Frailty is a loosely defined syndrome of the elderly characterized by weakness and impaired function. Frailty has been characterized by the inability to stand from a seated position with arms folded or walk 10 ft 41 and back in less than 10 seconds. Somewhat more complex criteria include both functional status and comorbidities with considerations of impaired mobility, vision loss, difficulty with cooking, bathing, grooming or toileting, diabetes, hypertension and limb tone abnormality. Of relevance to critical care, frail elderly have impaired immune function, altered mental status and anemia.43-4 The association of frailty with increases in IL-6 and D-dimer levels46 is of particular interest since activation of inflammatory and coagulation pathways could be relevant to critical care problems including multiple organ dysfunction syndrome, adult respiratory distress syndrome (ARDS) and pulmonary embolism. While the full relevance of frailty to critical care remains an area of research, considerations of prognosis may need to include recognition that frail elderly have decreased long-term survival42 and that impaired function is a poor prognostic factor ( Figure 1 ).'47 Impaired function as indicated by the simple requirement for assistance with bathing predicts increased in-hospital mortalityi48 Patients who are not functionally independent at the time of admission have only a 5% chance of one-year survival if prolonged critical care is required. After adjustment for age, severity of illness, comorbidities, gender and ethnicity, the degree of functional disability may be predictive of in-hospital mortality, one-year mortality, nursing home use and hospital cost. 49 Patients without functional limitations may have no age-associated risk with critical care in contrast to patients over age 75 with functional limitations who have a six-fold increase in hospital mortality. 50 Frailty, functional disabilities and comorbidities can be associated with nutritional deficiencies. Frailty has been associated with activation of inflammatory pathways,46 a catabolic state and impaired nutrition.5i,52 Comorbidities including chronic obstructive pulmonary 2.5 disease (COPD), malignancy, dementia and malabsorption are well recognized to impair nutrition through disparate mechanisms. An inter-relationship of inflammation and malnutrition sometimes referred to as a malnutrition-inflammation complex53 that may be related to increased inflammatory cytokines, a catabolic state and anorexia could be important in critical care. Although multiple mechanisms are relevant, it is clear that poor nutrition is very relevant to prognosis. Hypoalbuminemia is associated with increased postoperative complications,54'55 prolonged hospitalization with pneumonia56 and disability and mortality after stroke.57 Each 10 g/L decline in albumin has been reported to increase the odds of mortality by 137% and prolong ICU care by 28%.58 It is of interest that nutritional deficiencies, comorbidities and inflammatory processes may be interrelated and it is clear that patients who have nutritional deficiencies at admission are at risk of poor outcome with critical care.
Comorbidity and impaired organ system function Although the cumulative effects of past pathology and an increased prevalence of active disease cause marked heterogeneity in the elderly population, impairments in pulmonary, renal, hepatic, neurologic, immunologic and cardiovascular function are relatively predictable with age. Toxic effects of alcohol or tobacco and of disease processes including pneumonia, stroke and myocardial infarction are common with variable loss of function. As organ function declines, reserves required to respond to stress are impaired and homeostatic responses are reduced or slowed. Although some degree of impairment may be consistent, the multiple factors that contribute lead to marked variability such that age becomes a poor basis for prediction of function.
Age-related declines in organ function are not commonly a direct cause of symptoms in the absence of stress. In contrast, reduced reserves and impairments in homeostatic compensation can exacerbate other pathology and markedly complicate critical care. Many diseases are more prevalent with age. Problems including venous thromboembolism, anemia, diabetes, COPD, heart failure, vascular disease, dementia and infection are both common and can present particular challenges with respect to critical care and ventilatory support. While discussion of all potential comorbidities is not feasible, common problems are included that exemplify how comorbidities can complicate critical care.
Venous thromboembolic disease
The risk for venous thromboembolism increases with age. Although mechanisms are not fully understood, procoagulant factors including fibrinogen increase while antithrombin levels tend to decrease. Activation of coagulation pathways as reflected by increased Ddimer is common59 and has been recognized in the frail 46 elderly. Older patients also have an increased prevalence of diseases that confer additional risk including malignancy, heart failure, infection and stroke. Critical care with immobilization, mechanical ventilation and frequently infection or surgery is associated with further risks. Elderly patients in the ICU are consequently at very high risk. Prophylaxis to prevent deep vein thrombosis (DVT) may consequently be of particular value in the critically ill elderly. Of concern, even with prophylaxis the incidence of DVT in patients requiring mechanical ventilation over 7 days has been reported at 23.6%.60 While most forms of prophylaxis including stockings, intermittent calf compression, lowdose heparin and low-molecular-weight heparin (LMWH) have some efficacy, data concerning optimal prophylaxis for older patients in the ICU are limited. It is likely that the marked procoagulant stimulus common in critical illness may require higher doses of anticoagulants or combined modalities such as LMWH and intermittent calf compression. Low-molecular-weight heparin (enoxaparin 40 mg QD) was as effective or slightly better than SQ heparin (5000 TID) in one study of patients (mean age 70) with heart failure or severe respiratory disease. 6, Diagnosis and treatment of thromboembolic disease may also be more complex in the critically ill elderly.62 Initial evaluation with measures of D-dimer is problematic since D-dimer is increased with age and the specificity of the test for pulmonary embolism may decrease to 1 0% for those over 80.59New thrombosis can be difficult to identify in patients with past DVT. Studies with contrast are more dangerous in the setting of renal insufficiency that is common with age and critical care. Finally, evaluation of possible pulmonary embolism can be compromised in the presence of chronic lung disease and in patients requiring mechanical ventilation.
Thromboembolic disease may be a particular risk for patients with chronic pulmonary disease. Patients with reduced cardio-pulmonary function are at increased risk of mortality with pulmonary embolism. Patients with COPD who suffer a pulmonary embolism are at nearly two-fold increased risk of death during the following year compared to other COPD patients.63
Although anticoagulation is necessary for patients at any age, careful monitoring is warranted since the elderly may be at increase risk of bleeding. Anemia Anemia is a common problem with a prevalence of over 14% at age 80 and 40% for men over age 90.65 Although anemia often reflects underlying disease, it is likely that the elderly have a degree of hematopoetic dysfunction66 that becomes apparent with demands for increased hematopoeisis. Inflammatory cytokines that suppress hematopoeisis may be increased with age67 and critical illness. Gastrointestinal blood loss is common and blood sampling during critical care may average more than 40 mL/day. The combination of decreased hematopoeisis and increased blood loss has the consequence that by day 3 of intensive care 95% of patients may be anemic.68 Anemia in the elderly is associated with adverse outcomes or mortality.69
Anemia in advanced heart failure is known to be associated with decreased survival.70 Even mild anemia is associated with an increased risk for death with surgery.7'
Despite the risks associated with anemia, treatment with transfusion is of unclear efficacy. Although transfusion during critical care is common with as many as 85% of patients who are in the ICU over a 72 week receiving transfusion, adverse consequences are not infrequent and transfusion may not be as effective as expected. Transfusion has been associated with immunosuppressive effects, volume overload and acute lung injury. Blood is often stored for a period of time sufficient (e.g., over 15 days) to impair oxygencarrying capacity and cause increased inflammatory cytokines. Indeed the longer duration of blood storage has been associated with increased incidence of post- 74 operative pneumonia. Although transfusion can improve outcome for anemic patients with cardiac disease,75 transfusions have also been associated with diminished organ function and increased mortality.7677
Since transfusion may have adverse consequences, approaches that could minimize blood loss or increase hematopoeisis may be ofvalue. Erythropoietin can reduce transfusion requirements in the critically ill,78 although it is unclear whether clinical outcomes are improved.
Critically ill elderly patients have an increased prevalence of both anemia and cardiac disease leading to increased indications for transfusion. However, since the elderly may also be at increased risk of immune suppression, infection or impaired organ function, adverse effects from transfusion are ofparticular concern.
Renal failure The elderly have a decrease in renal mass in association with reduced renal blood flow and fewer functional glomeruli.79 Glomerular filtration rate (GFR) usually decreases by an average of 1 mL/min for each year over age 50 although the rate of decrease is variable and the GFR can remain in the normal range.80 Factors other than age, including blood pressure, protein intake and vascular disease are variable but very relevant to changes in GFR.
Estimation of GFR is important in critical care as a reflection of renal perfusion, for calculations of medication dose and as an indication of renal function. Unfortunately, serum creatinine is not an accurate reflection of GFR since creatinine excretion decreases with age. Formulas based upon serum creatinine, sex and age can provide a somewhat better estimate of creatinine clearance although accuracy remains lim- 81 ited. Careful monitoring of drug concentrations is particularly important in the elderly.
Impaired renal function complicates management of fluid and electrolyte balance. Reduced ability of the senescent kidney to regulate sodium excretion predisposes to volume depletion as well as overload, such that fluid administration must be closely monitored. Responses to renal perfusion pressure and angiotensin II may be impaired. A combination of impaired cardiovascular function with reduced renal capability to compensate for volume stress in the context of modestly excessive volume administration can rapidly precipitate pulmonary edema.
Pulmonary function with age
Although lung function invariably declines with age, the magnitude of change can be markedly affected by disease, smoking and environmental factors. Elastic recoil and compliance decrease. Collagen increases, collagen cross-linking increases and elastic fibers decrease.82 With these changes in supporting tissues there are decreases in airway size. Bronchiolar diameter progressively decreases after age 40.83 A reduction in airway size is associated with increased airway resistance. FEVy declines at a rate of 20-30 mL/year with a potentially greater rate of decrease after age 65.84 Rigidity of the thoracic cage increases, causing a greater dependence on the diaphragm and less use of thoracic muscles. In combination with an age-related reduction in diaphragmatic strength,85 chest wall stiffness may predispose to fatigue. Loss of elastic recoil and chest wall changes reduce vital capacity and increase residual volume. Small airways close more distally leading to an increased closing volume. Closing volume begins to exceed supine functional residual volume at about 45 years of age. Ventilation -perfusion mismatching increases with age as a result of small mm.CRqwrail.oom 
Pneumonia
Both the incidence and mortality of pneumonia increase with age. The mortality of community acquired pneumonia that requires critical care approaches 40% in the elderly.88 Nosocomial pneumonia may occur in 10% of patients over age 7089 with mortality that approaches 50%.9°Major risk factors in the elderly include nutritional deficiency, impaired functional status and comorbidities. Impaired pulmonary function with reduced ability to clear secretions and increased closing volume, aspiration, previous cerebrovascular accident (CVA), reduced albumin and congestive heart failure are all associated with increased risk and worse outcome from pneumonia. The combination of age, comorbidities, impaired motor function and renal failure has high risk of mortality.91 Severity of disease at admission, complications including ARDS and hospital-acquired superinfection have been related to outcome.2 Because of the high risk of adverse outcomes, antimicrobial therapy may be particularly important in the elderly. If a specific pathogen has been identified then the selection of antibiotics is relatively straightforward. Empiric treatment may be more complex and has been the subject of recent reviews and guidelines. [93] [94] [95] [96] Antibiotic selection and dosing in elderly patients must include consideration of decreases in renal function. Careful use of antibiotics is important since older patients may also be at increased risk of colonization with resistant organisms as well as adverse antibiotic effects including Clostridium difficile diarrhea.97 Elderly patients hospitalized with pneumonia may have a better outcome with a second-generation cephalosporin plus macrolide, a nonantipseudomonal third-generation cephalosporin plus macrolide or fluoroquinolone alone rather than beta-lactam/beta-Chrnric Resjratory Disese lactamase inhibitor plus macrolide or aminoglycoside with another agent.98 Although the elderly may be at some increased risk of complications, the value of treatment is well established and age should not be a basis for withholding of aggressive treatment.99 COPD Chronic obstructive lung disease is a major critical care problem both as a primary cause of admission and as a complicating factor of pneumonia and mechanical ventilation. Exacerbation of COPD is a common indication for ventilatory support. The hospital mortality for patients admitted to the ICU for COPD is in the range of 24% and patients over age 65 have been reported to have a one-year mortality of 59%.100
Hospital mortality was increased from 10.2% from those under age 65 to 32.9% for those over 65. However, nonrespiratory severity of illness as assessed with APACHE III score and duration of pre-ICU hospitalization may be more important prognostic factors than age. Severity of the COPD exacerbation and a requirement for mechanical ventilation may be of borderline significance (P = 0.07) with respect to mortality l10 when other risk factors are considered.
Evaluation of patients over age 55 with a diagnosis of COPD (average age 70) indicated that there is substantial variation in emergency room care that may not always be consistent with common guidelines.10'
Although older patients may have atypical symptoms and potentially be at increased risk of hypoxemia or hypercarbia, only 31% had spirometric evaluation and only 48% had arterial blood gas determinations. Bronchospasm and hypercapneic respiratory failure that commonly occur with COPD exacerbation are common to many pathologic processes. Diseases prevalent with age including pneumonia, pulmonary embolism, cardiac ischemia and congestive heart failure can cause similar symptoms or contribute to COPD symptoms. Careful evaluation with consideration of chest X-ray, EKG, blood gases and sputum microbiology may be particularly important for the elderly.
Bronchodilators, antibiotics and corticosteroids are efficacious but must be used with some caution in elderly patients. Beta-agonist bronchodilators have been associated with risks of cardiac ischemia and heart failure. 02,103 Older patients with an increased prevalence of coronary disease require care with respect to higher doses and initiation of beta-agonists. Antibiotics have value in treatment of COPD exacerbations104 and outpatient antibiotic treatment for elderly patients may reduce short-term mortality.'05 However, since pathogenic organisms cannot always be identified in the 'll Nevertheless, corticosteroids have significant adverse effects including hyperglycemia, delirium, osteoporosis and oral candidiasis that are of particular concern in older patients. Some adverse medication effects such Achilles tendon rupture associated with the combination of fluoroquinolones, steroids and age'15 are very relevant to elderly patients with COPD. Theophylline may not be an optimal selection in most critically ill elderly but, if used, levels should be monitored carefully since variable levels have been noted with age. 16 Consistent with other aspects of critical care, elderly COPD patients clearly benefit from treatment but may also be at risk of adverse effects. Exacerbation COPD frequently precipitates consideration of mechanical ventilation with concern that elderly patients who have severely compromised pulmonary function may be at increased risk of complications and poor outcome. Noninvasive positive pressure ventilation can provide support in many patients and may be well tolerated in the elderly.117"118
Since ventilator-associated pneumonia may be a risk for prolonged hospitalization'19 and in some cases mortality,1 the lower rate of pneumonia associated with noninvasive ventilation12 is a major advantage.
Although patients who are significantly underweight, poorly nourished or very ill may not be optimal candidates for noninvasive ventilation, these patients may also not tolerate mechanical ventilation well and increasingly severe disease is being treated with noninvasive ventilation.122 Patients with functional limitations at admission, hyperglycemia and lower pH have a poor prognosis and are more likely to ultimately require intubation. 123 Progressive respiratory acidosis with pH less than 7.2-7.25, particularly in combination with altered mental status, difficulty clearing secretions and ineffective breathing pattern indicates a need for mechanical ventilation.124
Although patients admitted to the ICU with a COPD exacerbation have a hospital mortality of 24%,1 even patients requiring mechanical ventilation can improve rapidly such that ventilatory support can be discontinued after a few days.124 Characteristics that suggest a poor prognosis include low baseline FEV1, chronic oxygen use, low albumin, low sodium, low BMI, poor functional status and multiple comorbidities. As with other aspects of critical care, elderly patients have an increased prevalence of problems that may portend a poor prognosis but age as an independent factor provides inadequate information with respect to treatment for respiratory failure from COPD exacerbation.
Definitive interventions for COPD in the elderly are limited. Although COPD is a common indication for lung transplant, the procedure is relatively high risk and transplant availability is a problem. Bilateral lung transplant is most commonly pursued for patients 50-55 years of age while single lung procedures are 128 more common at age 60-65. Lung reduction surgery is based upon the concept that removal of severely damaged, minimally functional lung parenchyma may reduce lung volume and allow the remaining lung to improve with respect to elastic recoil and airway caliber. Patients with severe airflow obstruction, residual volume over 150-200% predicted and heterogeneous disease are candidates while age over 75 years, marked hypercapnea, symptomatic heart disease and malnutrition are often considered relative contraindications. 29 Quantitative computed topography (CT) scan may be of value to help define appropriate candidates with respect to heterogeneity of disease.130
Unfortunately, neither transplant nor lung reduction surgery are optimal considerations for the very elderly.
ARDS
The incidence of adult respiratory distress syndrome (ARDS) increases with age. Mortality may increase from 12% in patients under age 60 to as high as 69% in those over age 60.131 Adverse consequences of ARDS persist beyond the period of hospitalization with decrease in health-related quality of life after discharge. 32 Improved approaches to treatment potentially including use of lower ventilation volumes and permissive hypercapnea have been associated with improved prognosis. 33 Although increased age has not been associated with poor outcome in all studies,'34 improvements in mortality have been more prominent in younger patients than the elderly.135
Most patients with ARDS have progression of disease over the first week often with cardiac, gastrointestinal, renal and hepatic dysfunction. Survivors tend to have failure of fewer organ systems and usually begin to improve by two weeks. Prolonged ventilator support over three weeks is associated with multiple organ system failure and increasing mortality. 136 wA.CRqwail.oom The pathophysiologic reasons that ARDS is frequent in the elderly is not established. Although an intense inflammatory response and activation of coagulation pathways are recognized with ARDS,"'"' it is not clear how changes in inflammation with age"'139 are relevant to ARDS. Nevertheless, it could be of importance if alterations in inflammatory response and endothelial function contribute in the pathogenesis of ARDS.140 Since therapeutic interventions such as low-dose corticosteroid that may reduce inflammation have been shown to have potential benefit in severe sepsis and ARDS,141 further work to characterize the relationship of ARDS to inflammation and treatment of inflammation in the elderly may be of importance.
Mechanical ventilation
The requirement for ventilator support is associated with a significant mortality risk for all patients. Long-term ventilator support is associated with a one-year mortality that exceeds 50% even for adults under age 64." The elderly have an increased risk that may be partially age related but is also importantly related to frailty, functional deficits, nutritional deficiency and comorbidities. " A large study in multiple countries identified an odds ratio for ICU mortality of 2.1 (CI 1.71-2.76) for patients over age 70.143 In contrast, a smaller study of selected patients suggested that age is not necessarily a major factor since patients over age 75 had a mortalitX of 38.1% compared with 38.8% for younger patients. It is likely that both studies are correct. Age may be associated with increased risks from mechanical ventilation but a subgroup of elderly can be identified who tolerate and benefit from ventilator support similarly to younger patients.
The disease process that precipitates a requirement for mechanical ventilation is of major relevance to risks and outcome. Indications for mechanical ventilation include acute lung injury, exacerbation of chronic lung disease, cardiac disease, neurologic disease, multisystem organ failure, neuromuscular disease or surgery.142 Acute lung injury and ARDS may have age-associated increases in mortality. After adjustment for covariates including severity of illness, age over 70 was associated with a hazard ratio of 2.5 (CI 2.0-3.2) for death in patients with acute lung injury.39 Similarly, after adjustment for severity of illness, patients with ARDS over age 55 may have an age-associated increase in mortality (64 versus 45%). 44 The duration of required ventilator support and costs may also increase with age.145'146 However, although patients over 80 years of age with respiratory failure have a survival rate of only 21% with ARDS, survival increases to 47% with COPD and 66% with drug overdose.27 While transient ventilator support for drug overdose may be associated with a relatively good short-term outcome regardless of age, severe pulmonary fibrosis that requires ventilator support may be associated with poor outcome even in younger patients. 147, 148 Despite significant mortality, many elderly patients can benefit from ventilator support. In a large review of patients from 1975 to 1985, 44% of patients under 80 and 30% of patients over 80 years of age survived to discharge. Longer duration of mechanical ventilation and increasing age do combine to confer a poor prognosis ( Figure 2) . As age plus the number of ventilator days approaches or exceeds 100, mortality approaches 100%. 4 As with other aspects of critical care in the elderly, outcome following mechanical ventilation is dependent upon functional status, comorbidities and severity of illness. Chronic renal disease, liver disease, cancer, systemic illness or malnutrition reduced survival from 30 to 7% in patients over age 80.27 A study comparing patients over age 75 with younger patients, with adjustment for severity of illness, found no increase in mortality or cost specifically related to age. 26 These results indicate that patients most likely to benefit from mechanical ventilation can be identified, while excluding those at highest risk of complications and poor outcome. Since many elderly survive critical illness requiring ventilator support and assuming that survival would be unlikely without intervention, it becomes apparent that mechanical ventilation can provide value in the elderly. It is not well established whether methods of ventilatory support should be changed with age. Lower tidal volume ventilation for ARDS appears similarly efficacious in both elderly and younger patients. 39 The potential value of prone positioning has not been well studied with age. Older patients may have greater difficulty with weaning and extubation. Patients with acute lung disease over age 75 had a significantly longer time required for weaning and increased rate of reintubation. 39 49 While it is not well established that reintubation is the cause of adverse outcomes, patients who require reintubation have increased nosocomial pneumonia and mortality.'50'15' The elderly may consequently require particular caution with respect to discontinuation of ventilator support.
Conclusions
Although age is associated with risk of adverse events and increased mortality, severity of illness, functional status, nutrition and comorbidities are of primary importance with respect to critical care outcomes. Potential interventions must be considered in the context of health status and comorbidities to determine whether an elderly patient is likely to benefit from critical care. Patients who require prolonged ventilatory support, have multiple chronic systemic diseases and poor functional status are at particular risk of poor outcome. Patients who are independently able to perform activities of daily living, have a good nutritional status and few comorbid conditions have a favorable prognosis regardless of age. The indications for critical care are clearly relevant to potential outcomes. Conditions amenable to treatment such as COPD exacerbation have a better short-term prognosis than disease that is poorly responsive to therapeutic interventions such as severe pulmonary fibrosis.
Critical care of elderly patients often requires evaluation and treatment of multiple, complex problems. While risks of cost, prolonged discomfort and disability may be increased with age, the indications for care and potential value of critical care may also increase with age. Critical care and ventilatory support of elderly patients can be particularly challenging but can also provide major value.
